Limited therapeutic options are available for pulmonary fibrosis because its molecular pathogenesis remains unclear. Here, the authors show that the CCL20– integrin α5β1–TGF β signaling cascade could be a potential therapeutic target for pulmonary fibrosis.
- Suosi Liu
- Qianrong Wang
- Shanshan Liu
